new caution about using phenytoin (Dilantin, etc) or fosphenytoin (Cerebyx) in certain patients of Asian descent

January 2009

You'll hear a new caution about using phenytoin (Dilantin, etc) or fosphenytoin (Cerebyx) in certain patients of Asian descent.

This is similar to the recent warnings for carbamazepine.

The FDA now recommends testing for the HLA-B*1502 gene before starting carbamazepine in Asians.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents